Mexico Mammography Market Size (2024 - 2029)

Mexico Mammography Market Analysis

The Mexico Mammography Market size is estimated at USD 38.75 million in 2024, and is expected to reach USD 54.72 million by 2029, growing at a CAGR of 7.15% during the forecast period (2024-2029).

As a result of the COVID-19 pandemic, numerous surgeries and treatments were halted, raising concerns regarding the length of the delay before the diseases pose a risk to the patient's health. Likewise, the impact of the pandemic on the Mexican mammography market was fairly adverse on account of the postponement or cancellation of elective procedures. To curb the spread of the virus, the Mexican government undertook several reforms by limiting the use of healthcare facilities for patients other than those suffering from COVID-19. As breast cancer screening was listed as an elective procedure, numerous appointments were rescheduled or canceled in March 2020, depending on the situation in particular areas of the country. As a result, the number of mammography procedures declined on account of movement restrictions and social distancing norms. As per the data published by the World Health Organization in March 2022, COVID-19 resulted in delayed screening of breast cancer across Mexico which has led to complications among the women having breast cancer. Hence, it is observed that the market studied was significantly hampered during the COVID pandemic.

The major factors affecting the growth of the market are the rising incidence of breast cancer, huge R&D in breast cancer therapies, and advances in breast imaging modalities. Over the past few years, the market for mammography devices has been expanding in Mexico due to the growth of its per capita income, increase in healthcare investment, and the availability of domestic and foreign companies selling their products. Additionally, factors such as the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and the investment from various organizations in breast cancer screening campaigns affect the market's growth. Additionally, according to the World Health Organization, the number of mammographs done per 10,000 breast cancer patients was 64.4 in 2020. Although this number is slightly low, since Mexico is an upper-middle-income country, it is relatively high compared to developing countries. Additionally, the Globocan 2020 report stated that as of 2020, Mexico saw 29,929 cases of breast cancer, and breast cancer was ranked number one by both incidence and mortality. This is expected to boost the demand for mammography devices. Thus, the availability of advanced mammography services and high disease incidence are expected to boost market growth during the forecast period.

Mexico Mammography Industry Segmentation

As per the scope of the report, mammography refers to a standard diagnostic and screening technique that is used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-energy X-rays for the early detection of breast cancer. Mexico Mammography Market is segmented by Product Type (Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Product Types), End Users (Hospitals, Specialty Clinics, and Diagnostic Centers). The report offers the value (in USD million) for the above segments.